semaglutide news oct 26 2025 Troubling Findings in Study of GLP-1 Compounders semaglutide news october 26 2025

If pregnancy is achieved, discontinuation of the drug is advised due to the lack of evidence regarding its safety during pregnancy

We have relied upon personal experiences, expert opinions, investigations, well-charted trials and a whole gamut of pharmaceutics to improve the care of CKD patients, but we have yet to minimize our patients risks to the point of halting DKD

Bratulic, Lillys Q1 revenue surge overshadowed by CVS dumping Zepbound for Wegovy | FirstWord Pharma, FirstWord Pharma (2025)

Many patients begin noticing appetite changes within the first few weeks of treatment, with gradual weight loss occurring over time